Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage.
about
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.Her2 positivity and race predict higher mastectomy rates: a SEER database analysis.Re-irradiation for locally recurrent refractory breast cancer.Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancerProgesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients.Expression of Axl and its prognostic significance in human breast cancer.A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK).Cause-specific mortality in women with breast cancer in situ.BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.Integrated analysis of somatic mutations and immune microenvironment of multiple regions in breast cancers.Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer.Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry.Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts - a systematic review and meta-analysis.Estimating changes in the rate of synchronous and metachronous metastases over time: Analysis of SEER data.Enhanced Bone Metastases in Skeletally Immature Mice.The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
P2860
Q30847275-FE3A87F5-B972-451F-84EA-63F0E3394BC0Q33596330-49C8695D-D1D5-4891-B0C7-7FD7D778FBD8Q36308052-3ADBD3D4-740B-4D05-8899-1E0B08335B35Q36544299-2E817C34-6801-4F17-8B95-75E451E50B50Q36545695-63A49017-D0D2-4711-8FF7-88BE9111CB80Q36844266-7ADBA8A8-C429-441B-8382-F4B23B51646CQ37109499-51C4CCDF-95B6-4E1F-AED7-9EEE88D9195CQ37701037-E5497A49-F2B6-4863-85A8-C8DA3D07856AQ38839151-34CC0CD5-0F08-4F45-8867-5F210E2718F6Q39699318-EEC8FA35-9BB3-48D8-9C63-3F9674731D04Q40595247-A9B39EFB-92D0-4766-A73B-83161D1BEA2EQ40870110-E0612BC0-2D84-400F-9A95-B8FC177B130DQ41790940-8058706A-9A8B-4B69-9F2E-D44252BD2418Q42654606-C6D0C317-BAA6-4A1F-BBEE-7A1444D6CB63Q47153479-EAB8FD43-8897-40DC-BBA6-9088C8805A6AQ47179544-4F1AD80E-B9E4-43A8-BF01-D91F0F06F80FQ52632722-D64901DF-E7D4-4997-9DE2-002C41F479AAQ55074323-86F3F469-7741-47A7-9973-4C1417FD15CBQ55241581-32D1729D-7E17-4142-8BFD-4EFCC669E8BBQ55426366-C2E793B5-73B3-4081-9855-017BAB7C135AQ55509868-F8A96118-FFA3-468C-A7BD-EFDA10310DFF
P2860
Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Trends in 5-year survival rate ...... one receptor status and stage.
@ast
Trends in 5-year survival rate ...... one receptor status and stage.
@en
Trends in 5-year survival rate ...... one receptor status and stage.
@nl
type
label
Trends in 5-year survival rate ...... one receptor status and stage.
@ast
Trends in 5-year survival rate ...... one receptor status and stage.
@en
Trends in 5-year survival rate ...... one receptor status and stage.
@nl
prefLabel
Trends in 5-year survival rate ...... one receptor status and stage.
@ast
Trends in 5-year survival rate ...... one receptor status and stage.
@en
Trends in 5-year survival rate ...... one receptor status and stage.
@nl
P2093
P2860
P1476
Trends in 5-year survival rate ...... one receptor status and stage.
@en
P2093
Benjamin O Anderson
Christopher I Li
Hannah M Linden
P2860
P2888
P304
P356
10.1007/S10549-014-3112-6
P407
P577
2014-08-28T00:00:00Z
P5875
P6179
1045674712